Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer

Articles Ahead of Print

MALAT1 as a Versatile Regulator of Cancer: Overview of the updates from Predatory role as Competitive Endogenous RNA to Mechanistic Insights

Volume:21
Ammad Ahmad Farooqi*, Evangelia Legaki, Maria Gazouli, Silvia Rinaldi and Rossana Berardi

Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma

Volume:20
Zhijun Chen, Kexin Cao, Jinghang Zhang, Zhuangzhuang Liu, Liaoxun Lu, Bo Qi, Lijin Shi, Rong Huang* and Song Zhao

Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study

Volume:20
Irina R. Gilyazova, Narasimha M. Beeraka, Elizaveta A. Klimentova, Kirill V. Bulygin, Vladimir N. Nikolenko, Adel A. Izmailov, Gulshat R. Gilyazova, Valentin N. Pavlov, Elsa K. Khusnutdinova, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev*

Modulation of Matrix Metalloproteinases by Plant-Derived Products

Volume:20
Nur Najmi Mohamad Anuar*, Nurul Iman Natasya Zulkafali and Azizah Ugusman

Acid ceramidase, a double-edged sword in cancer aggression: A minireview

Volume:20
Helen Shiphrah Vethakanraj, Niveditha Chandrasekaran and Ashok Kumar Sekar*

Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1

Volume:20
Junqi Cui, Xiaobo Zhou, Jia Huang, Jiahua Cui and Jun Chen*

Management of Prostate Cancer with Systemic Therapy. A Prostate Cancer Unit Perspective

Volume:20
Fabio Campodonico*, Marco Ennas, Silvia Zanardi , Ekaterini Zigoura, Arnoldo Piccardo, Luca Foppiani, Concetta Schiavone, Lino Squillace, Andrea Benelli, Andrea De Censi , Filippo Grillo-Ruggieri and Carlo Introini

MUC glycoproteins: Potential biomarkers and molecular targets for cancer therapy

Volume:20
Chameli Ratan, Dalia Cicily K. D, Bhagyalakshmi Nair and Lekshmi R. Nath*

Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome

Volume:20
Valentina Coccè, Arianna Bonomi, Loredana Cavicchini, Francesca Sisto, Aldo Giannì, Giampietro Farronato, Giulio Alessandri, Francesco Petrella, Valeria Sordi, Eugenio Parati, Gianpietro Bondiolotti, Francesca Paino and Augusto Pessina*

Potential Role of miRNA in Mestastatic Cascade of Triple Negative Breast Cancer

Volume:20
Acharya Balkrishna, Rashmi Mittal and Vedpriya Arya*

Immunotherapy: A Potential Approach To Targeting Cancer Stem Cells

Volume:20
Wenjun Wang, Ling Bai, Dongsheng Xu, Wei Li and Jiuwei Cui*

Withdrawn: The Structural Bioinformatics Analysis of Biophenolic Lignan- Estrogen Receptor Interaction

Volume:17
Farzaneh Mohamadyar-Toupkanlou*, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri Renani and Masoud Soleimani